Clinical Trial: An Exploratory Study on the Role of Dysregulated Phosphatidylcholine and Sphingomyelin Metabolism in the Shared Biological Mechanisms Underlying Antipsychotic Treatment Response and Metabolic Disturbances (China)

Posted On: 2026-11-06

China, Nov. 6 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An Exploratory Study on the Role of Dysregulated Phosphatidylcholine and Sphingomyelin Metabolism in the Shared Biological Mechanisms Underlying Antipsychotic Treatment Response and Metabolic Disturbances'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136071

Registration Time: 2026/11/05

Type: Observational study

Primary Sponsor: Peking University Sixth Hospital ( Institute of Mental Health )

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=350165

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: An Exploratory Study on the Role of Dysregulated Phosphatidylcholine and Sphingomyelin Metabolism in the Shared Biological Mechanisms Underlying Antipsychotic Treatment Response and Metabolic Disturbances (China)